Keyphrases
Texas
100%
US Population
100%
Atherosclerosis Prevention
100%
Air Force
100%
Prevention Studies
100%
Coronary Atherosclerosis
100%
Baseline Characteristics
100%
Cholesterol
66%
Placebo
66%
High-density Lipoprotein Cholesterol (HDL-C)
66%
Lovastatin
66%
Hispanic
33%
Low-density Lipoprotein Cholesterol Level
33%
Lipid Levels
33%
Population-based
33%
Placebo-controlled
33%
NHANES III
33%
Elderly Subjects
33%
Triglyceride Level
33%
Total Cholesterol Level
33%
Primary Prevention Trials
33%
Major Coronary Events
33%
Clinical Evidence
33%
Low Saturated Fat
33%
Atherosclerotic Cardiovascular Disease (ASCVD)
33%
Low-cholesterol Diet
33%
Level Characteristic Values
33%
Large Segment
33%
Nursing and Health Professions
Placebo
100%
Cohort Analysis
100%
Coronary Artery Atherosclerosis
100%
High Density Lipoprotein Cholesterol
66%
Mevinolin
66%
Low Density Lipoprotein Cholesterol Level
33%
Primary Prevention
33%
Lipid Level
33%
National Health and Nutrition Examination Survey
33%
Triacylglycerol Level
33%
Total Cholesterol Level
33%
Saturated Fatty Acid
33%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Coronary Artery Atherosclerosis
100%
Cohort Study
100%
High Density Lipoprotein Cholesterol
66%
Mevinolin
66%
Low Density Lipoprotein Cholesterol
33%
Triacylglycerol
33%
Saturated Fatty Acid
33%
Medicine and Dentistry
Placebo
100%
Cohort Analysis
100%
High Density Lipoprotein Cholesterol
66%
Lovastatin
66%
Primary Prevention
33%
Low Density Lipoprotein Cholesterol
33%
Triacylglycerol
33%
Cholesterol Diet
33%
National Health and Nutrition Examination Survey
33%
Saturated Fatty Acid
33%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
HDL-Cholesterol
66%
Lovastatin
66%
Lipid Level
33%
Triacylglycerol Level
33%
Low Density Lipoprotein Cholesterol Level
33%
Saturated Fat
33%
Total Cholesterol Level
33%